These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 30717429)

  • 1. Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson's Disease?
    Vilaça-Faria H; Salgado AJ; Teixeira FG
    Cells; 2019 Feb; 8(2):. PubMed ID: 30717429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of exosomes in pathogenesis and the therapeutic efficacy of mesenchymal stem cell-derived exosomes against Parkinson's disease.
    Abrishamdar M; Jalali MS; Yazdanfar N
    Neurol Sci; 2023 Jul; 44(7):2277-2289. PubMed ID: 36949298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The potential use of mesenchymal stem cells and their exosomes in Parkinson's disease treatment.
    Heris RM; Shirvaliloo M; Abbaspour-Aghdam S; Hazrati A; Shariati A; Youshanlouei HR; Niaragh FJ; Valizadeh H; Ahmadi M
    Stem Cell Res Ther; 2022 Jul; 13(1):371. PubMed ID: 35902981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease.
    Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ
    Cells; 2020 Jan; 9(2):. PubMed ID: 32012897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-100a-5p-enriched exosomes derived from mesenchymal stem cells enhance the anti-oxidant effect in a Parkinson's disease model via regulation of Nox4/ROS/Nrf2 signaling.
    He S; Wang Q; Chen L; He YJ; Wang X; Qu S
    J Transl Med; 2023 Oct; 21(1):747. PubMed ID: 37875930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into the Effects of Mesenchymal Stem Cell-Derived Secretome in Parkinson's Disease.
    d'Angelo M; Cimini A; Castelli V
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32718092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical potential and current progress of mesenchymal stem cells for Parkinson's disease: a systematic review.
    Chen Y; Shen J; Ke K; Gu X
    Neurol Sci; 2020 May; 41(5):1051-1061. PubMed ID: 31919699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal Administration of Umbilical Cord Mesenchymal Stem Cell Exosomes Alleviates Parkinson's Disease.
    Huang W; Zhang T; Li X; Gong L; Zhang Y; Luan C; Shan Q; Gu X; Zhao L
    Neuroscience; 2024 Jun; 549():1-12. PubMed ID: 38705349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomes and Stem Cells in Degenerative Disease Diagnosis and Therapy.
    Chang YH; Wu KC; Harn HJ; Lin SZ; Ding DC
    Cell Transplant; 2018 Mar; 27(3):349-363. PubMed ID: 29692195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell secretome based approaches in Parkinson's disease regenerative medicine.
    Marques CR; Marote A; Mendes-Pinheiro B; Teixeira FG; Salgado AJ
    Expert Opin Biol Ther; 2018 Dec; 18(12):1235-1245. PubMed ID: 30422014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells and neuroregeneration in Parkinson's disease.
    Glavaski-Joksimovic A; Bohn MC
    Exp Neurol; 2013 Sep; 247():25-38. PubMed ID: 23542820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potentials of human microfluidic encapsulated conjunctival mesenchymal stem cells on the rat model of Parkinson's disease.
    Forouzandeh M; Bigdeli MR; Mostafavi H; Nadri S; Eskandari M
    Exp Mol Pathol; 2021 Dec; 123():104703. PubMed ID: 34619140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration?
    Teixeira FG; Carvalho MM; Sousa N; Salgado AJ
    Cell Mol Life Sci; 2013 Oct; 70(20):3871-82. PubMed ID: 23456256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prospective role of mesenchymal stem cells in Parkinson's disease.
    Tambe P; Undale V; Sanap A; Bhonde R; Mante N
    Parkinsonism Relat Disord; 2024 Oct; 127():107087. PubMed ID: 39142905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From regenerative strategies to pharmacological approaches: can we fine-tune treatment for Parkinson's disease?
    Silva RC; Domingues HS; Salgado AJ; Teixeira FG
    Neural Regen Res; 2022 May; 17(5):933-936. PubMed ID: 34558504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Parkinson's disease model with human umbilical cord mesenchymal stem cell-derived exosomes loaded with BDNF.
    Wang CC; Hu XM; Long YF; Huang HR; He Y; Xu ZR; Qi ZQ
    Life Sci; 2024 Nov; 356():123014. PubMed ID: 39182566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.
    Leggio L; Vivarelli S; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Marchetti B; Iraci N
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placenta-derived mesenchymal stromal cells and their exosomes exert therapeutic effects in Duchenne muscular dystrophy.
    Bier A; Berenstein P; Kronfeld N; Morgoulis D; Ziv-Av A; Goldstein H; Kazimirsky G; Cazacu S; Meir R; Popovtzer R; Dori A; Brodie C
    Biomaterials; 2018 Aug; 174():67-78. PubMed ID: 29783118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes from Human Periapical Cyst-MSCs: Theranostic Application in Parkinson's Disease.
    Tatullo M; Marrelli B; Zullo MJ; Codispoti B; Paduano F; Benincasa C; Fortunato F; Scacco S; Zavan B; Cocco T
    Int J Med Sci; 2020; 17(5):657-663. PubMed ID: 32210716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's Disease: From Genetics and Epigenetics to Treatment, a miRNA-Based Strategy.
    Paccosi E; Proietti-De-Santis L
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.